Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
University of Kansas
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Discovery of New Antibiotics from Deep Sea Actinomycete Bacteria
Training of New Users
Long Term Brain Behavior Effects of Delta 9 Thc
RNA Sequence Analysis Using Adaptive Statistical Models
Structure and Replication of Enveloped RNA Viruses
Recently added grants:
Developing chemical-proteomic tools to investigate cysteine oxidation
Enrichment Program
Phosphoinositide Signaling in the Cytosol and Nucleus
T-Cell Targeting for GVHD
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075035-005
Application #
6828780
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
NIH 2002
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
Comments
Be the first to comment on this grant